Skip to main content
SpringerLink
Log in

Drug safety risk minimisation websites easy to use but with low user engagement

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Smith MY, et al. Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom. Drug Safety : 8 Mar 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01165-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug safety risk minimisation websites easy to use but with low user engagement. Reactions Weekly 1897, 8 (2022). https://doi.org/10.1007/s40278-022-11245-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-11245-2

Search

Navigation